| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
BRKR
Bruker
|
Aug 04, 2026 | HOLD |
Buy
+6.5% avg upside
22 analysts
|
$60.00
19.28% Upside
|
+1.9% | · |
|
MYGN
Myriad Genetics
|
Jul 15, 2026 | HOLD |
Hold
+464.5% avg upside
24 analysts
|
$6.00
89.32% Upside
|
-50.1% | · |
|
TECH
Bio-Techne
|
Jun 30, 2026 | HOLD |
Buy
+15.8% avg upside
21 analysts
|
$73.00
1.19% Upside
|
+2.1% | · |
|
SEER
Seer
|
May 13, 2026 | BUY |
Strong Buy
+417.5% avg upside
5 analysts
|
— | +23.7% | · |
|
LAB
Standard BioTools
|
May 05, 2026 | HOLD |
Strong Buy
+668.5% avg upside
8 analysts
|
$1.35
64.45% Upside
|
-20.4% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.